Skip to main content

Why does Mounjaro require a gradual increase in dosage?

Medically reviewed by Kristianne Hannemann, PharmD. Last updated on March 6, 2025.

Official Answer by Drugs.com

Mounjaro (tirzepatide) is started at a low dose and gradually increased to help minimize side effects such as nausea and diarrhea. The dosage is typically raised every four weeks, allowing your healthcare provider to assess how well the medication is working and how your body is adjusting.

What is the starting dose of Mounjaro?

The initial dose of Mounjaro is 2.5 mg once weekly for four weeks. This is a starting dose and not intended for blood sugar control. After the first month, the dosage may be increased to 5 mg once weekly. Based on your response, your healthcare provider may continue increasing the dose every four weeks, up to a maximum of 15 mg per week.

What are the common side effects of Mounjaro?

The most frequently reported side effects include:

Gradually increasing the dose helps reduce these side effects by allowing your body time to adjust.

This is not a complete list of side effects. Speak with your healthcare provider about potential side effects and how to manage them.

This is not all the information you need to know about Mounjaro (tirzepatide) for safe and effective use and does not take the place of your doctor’s directions. Review the full product information and discuss this information and any questions you have with your doctor or other health care provider.

References

Mounjaro [package insert]. Updated Jan 2025. Eli Lilly and Company. Accessed 02/05/2025 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0

Read next

Mounjaro vs Ozempic: Which is right for you?

Mounjaro and Ozempic are prescription medicines used alongside diet and exercise to help control blood sugar (glucose) levels in adults with type 2 diabetes.

Ozempic is also approved to lower the risk of a major cardiovascular event (like a heart attack or stroke) in patients with type 2 diabetes, as well as to reduce the risk of worsening kidney disease and heart-related death in patients with type 2 diabetes. Mounjaro has not yet received these indications, although studies are ongoing.

You and your healthcare provider should discuss the risks vs. benefits and costs of these medications to determine which one is right for you.

Continue reading

Zepbound vs Mounjaro: Comparison Guide for Weight Loss and Diabetes Treatment

Zepbound and Mounjaro contain the same active ingredient (tirzepatide) and both are made by Eli Lilly and Company, but they have different FDA approved uses and insurance coverage. Zepbound is approved for chronic weight management and obstructive sleep apnea (OSA) and Mounjaro is approved for type 2 diabetes.

Continue reading

Why am I not losing weight on Mounjaro?

It takes time, about 8 to 12 weeks to see a 6% to 8% weight loss in adults using Mounjaro. Other reasons include the need to follow a reduced calorie diet and exercise program, your dose may need to be increased, or side effects may affect your treatment. Continue reading

See also:

Related medical questions

Drug information

Related support groups